We have previously shown a connection between histone H1 phosphorylation and the transcriptional competence of the hormone inducible mouse mammary tumor virus (MMTV) promoter. Prolonged exposure of mouse cells to dexamethasone concurrently dephosphorylated histone H1 and rendered the MMTV promoter refractory to hormonal stimulation and, therefore, transcriptionally unresponsive. Using electrospray mass spectrometry, we demonstrate here that prolonged dexamethasone treatment differentially effects a subset of the six somatic H1 isoforms in mouse cells. H1 isoforms H1.0, H1.1, and H1.2 are non-responsive to hormone whereas prolonged dexamethasone treatment effectively dephosphorylated the H1.3, H1.4, and H1.5 isoforms. The protein kinase inhibitor staurosporine, shown to dephosphorylate histone H1 and down-regulate MMTV in cultured cells, appears only to completely dephosphorylate the H1.3 isoform. These results suggest that dephosphorylation of specific histone H1 isoforms may contribute to the previously observed decrease in transcriptional competence of the MMTV promoter through the modulation of chromatin structure. In a broader sense, this work advances the hypothesis that post-translational modifications of individual histone H1 isoforms directly influence the transcriptional activation/repression of specific genes.
Eukaryotic DNA is efficiently organized into the highly ordered yet dynamic structure called chromatin (1, 2) . The primary, repeating structural unit of chromatin is the nucleosome and is composed of 146 base pairs of DNA wrapped around an octamer of four core histone proteins: H2A, H2B, H3, and H4 (3) . In addition, the linker histone or histone H1 protein binds to the linker DNA between nucleosomes and is thought to function primarily in the condensation of chromatin into higher ordered structures (4) . While the core histones are highly conserved in eukaryotes, with H4 being nearly invariant, histone H1 is much more evolutionarily diverse, and in mammals, consists of six somatic H1 isoforms (H1.0 through H1.5, using the nomenclature of Doenecke and co-workers, Ref. 5 ) and one testis-specific isoform (H1.t). The H1 isoforms share a common protein structural fold with the N-and C-terminal "tail" regions extending from a central globular domain. The central globular domain is primarily responsible for binding to DNA, while the tail regions function to modulate protein interaction with DNA (4) . It is generally accepted that histone H1 binds nucleosomes at the dyad axis and contacts duplex DNA as it enters and exits the nucleosome (6) . However, in the specific case of the 5 S rRNA gene from Xenopus, there is evidence to suggest that histone H1 binds asymmetrically to the nucleosome on a position off the dyad axis and within a DNA gyre (6 -8) .
A growing body of evidence suggests that the linker histones function in part to modulate transcriptional activity through chromatin organization (reviewed in Ref. 9 ). Initially, it was thought that histone H1 would have a general role in global gene activity, as actively transcribed genes are depleted of H1 proteins (10, 11) . However, studies have demonstrated that histone H1 differentially acts on specific gene sequences to control transcription. Shen and Gorovsky (12) showed, using a knockout technique in Tetrahymena thermophila, that H1 removal produces targeted and not global effects on gene activity. It was further shown that the phosphorylation of Tetrahymena histone H1 regulates specific gene activity by mimicking H1 removal from chromatin (13) . Studies in Xenopus oocytes have shown that H1 acts as a specific repressor of the 5S rRNA gene through the modulation of chromatin structure (14 -18) . In addition, Brown et al. (19) have studied the effect of overexpression of specific H1 isoforms on gene expression in mammalian cells and found in one instance that H1.0 overexpression led to specific gene repression while H1.2 overexpression lead to specific gene activation. In contrast, in the case of the mouse mammary tumor virus (MMTV) 1 promoter, overexpression of H1.0 and H1.2 isoforms was shown to increase both the basal and hormone-induced levels of the MMTV reporter gene transcript (20) .
The positively charged tails of the linker histones neutralize the negatively charged backbone of DNA and facilitate the structural organization of chromatin into higher ordered structures (4). Phosphorylation of specific serine and threonine residues in the C-terminal tail region of histone H1 is thought to loosen its interaction with DNA and serves to modulate protein function. Histone H1 phosphorylation is cell cycle-dependent. The phosphorylation level of the H1 isoforms is the lowest in the G 1 phase and increases as the cell cycle proceeds, with maximal phosphorylation occurring during M-phase (21) . Interestingly, hyperphosphorylation of histone H1, a state generally associated with the opening of chromatin domains, is correlated with mitotic condensation of chromosomes (22, 23 ), yet H1 phosphorylation does not appear to be a requirement for mitotic chromatin condensation in either mammals (24) or Xenopus oocytes (25) . While the phosphorylation status of bulk histone H1 has been well characterized in the different stages of the cell cycle, little is known about the role of phosphorylation in the cellular function of individual H1 isoforms. In addition, while histone H1 is a common in vitro substrate for numerous protein kinases, little is known about specific in vivo histone H1 modifying enzymes. Cdk2 is a cell cycle-dependent protein kinase known to act on histone H1 in vivo (26) , and recent evidence suggests that the kinase activity of Cdk2 toward H1 can be down-regulated in response to prolonged exposure to the synthetic glucocorticoid dexamethasone (27) .
We have shown previously that prolonged exposure of 1471.1 cells to the synthetic glucocorticoid dexamethasone significantly decreased the level of histone H1 phosphorylation (28) . Interestingly, the decrease in histone H1 phosphorylation after prolonged dexamethasone treatment was correlated with the MMTV promoter becoming refractory to glucocorticoid stimulation (28) . The MMTV promoter is an ideal system to study the relationship between chromatin structure and gene expression because of its well characterized chromatin architecture and hormone responsiveness (29, 30) . Dephosphorylated histone H1, when bound to the chromatin structure over the MMTV promoter, is thought to restrict chromatin remodeling and transcription factor access, which are necessary steps in the transcriptional activation of MMTV. Furthermore, exposure of cells to staurosporine, a potent kinase inhibitor, resulted in the complete dephosphorylation of histone H1 and the MMTV promoter becoming refractory to hormonal stimulation (28) . As the Western analysis used in our previous investigation did not differentiate between the specific histone H1 isoforms, we chose to investigate the phosphorylation status of the individual histone H1 isoforms in response to hormone treatment using mass spectrometry. Specifically, we investigated which isoforms were dephosphorylated in response to staurosporine and prolonged dexamethasone treatment and therefore may be responsible for the MMTV promoter's refractory state.
Using electrospray ionization mass spectrometry (ESI-MS), we have identified three H1 isoforms (H1.3, H1.4, and H1.5) that are responsive to hormone exposure; i.e. prolonged dexamethasone exposure results in a decline in the relative phosphorylation level of the isoforms. In addition, we show by ESI-MS that while staurosporine did not significantly affect the phosphorylation status of isoforms H1.0, H1.1, and H1.2, it decreased the level of H1.4 and H1.5 phosphorylation and completely dephosphorylated H1.3. These data suggest that phosphorylation of specific histone H1 isoforms can be modulated by hormone exposure.
MATERIALS AND METHODS
Cell Culture-Mouse 1471.1 cells, derived from a C127 parental cell line, were grown at 37°C in Dulbecco's modified Eagle's medium (DMEM) with 10% fetal bovine serum and 5% CO 2 (28 Histone H1 Purification-Histone H1 and other chromatin-related proteins are soluble in dilute acid and were initially extracted from whole cells using 5% perchloric acid. After centrifugation to remove 5) . The 24/24-hour Peak 1 and Peak 2 samples, lanes 4 and 5 respectively, were separated using RP-HPLC as shown in Fig. 1 . The top panel corresponds to a Western blot probed using the anti-phosphohistone H1 antibody while the bottom panel is a Gel-Code Blue-stained 16% SDSgel of the same samples used in the Western. The protein bands containing the different H1 isoforms are labeled based on mass spectrometry analysis of the samples (see Fig. 3 ). B, lane 1 depicts a portion of a 16% SDS-gel stained after transfer to the polyvinylidene difluoride membrane, corresponding to 3 g of acid-extracted proteins from the 24/24-hour sample. Lane 2 corresponds to the Western analysis, using the anti-histone H1 antibody, of the histone H1 proteins transferred from the same gel shown in lane 1. C, Western analysis using the phosphospecific H1 antibody against samples acid-extracted from 1471.1 cells co-treated for 24 h with staurosporine and dexamethasone. The top panel corresponds to a Western blot probed using the antiphosphohistone H1 antibody while the bottom panel is a Gel-Code Blue-stained 16% SDS-gel of the same samples used in the Western. cellular debris, the remaining soluble proteins were precipitated using trichloroacetic acid to a final concentration of 30%. The precipitated proteins were then washed twice with acetone, dried, reconstituted in water, and stored at Ϫ80°C until analysis. The histone H1 isoforms were further purified from other acid soluble proteins using an Agilent HP110 HPLC system and an Amersham Pharmacia Biotech Sephasil C 4 reverse phase column (5 m, 4.6/250 mm) with a linear gradient from 33 to 45% buffer B over 65 min. Buffer A consisted of water plus 0.05% trifluoroacetic acid, and buffer B consisted of acetonitrile plus 0.05% trifluoroacetic acid. The elution profile was constructed from absorbance measurements at 214 nm. Purified samples were dried, reconstituted in water, and stored at Ϫ80°C until use.
Electrospray Mass Spectrometry-A Micromass Q-Tof (Altrincham, UK) hybrid tandem mass spectrometer (31) was used for the acquisition of the ESI-MS spectra. The instrument is equipped with a nanoflow electrospray source and consists of a quadrupole mass filter and an orthogonal acceleration time-of-flight mass spectrometer. The needle voltage was ϳ3000 V, cone voltage was 60 V, collision energy was 4.0 eV, and the source was maintained at 80°C for the MS analyses. Samples for flow injection analyses were infused into the mass spectrometer at ϳ200 nanoliters/min using a pressure injection vessel (32) . Data were acquired over the m/z range of 50 -3000 at 1.9 s/scan. Data analysis was accomplished with a MassLynx data system and MaxEnt software supplied by the manufacturer.
The total relative phosphorylation level for each isoform was computed first by normalizing the intensity of each phosphorylated ion species to the unphosphorylated ion within each spectrum and (see Fig.  4 ), second, by taking the sum of the normalized intensities for the phosphorylated ions. The summed intensities were then normalized to the untreated sample to produce the numbers in Table II . While the direct comparison of ion abundance between different spectra cannot be made, comparison of the total relative phosphorylation levels of isoforms between spectra is possible. Although the addition of negatively charged phosphate groups to a protein generally reduces its ion abundance in the mass spectrometer in the positive ion mode, relative to the unphosphorylated species, the H1 isoforms have large overall positive charges with ϳ50 positively charged amino acid residues per isoform (4). Therefore, the addition of 1 or 2 phosphate groups per H1 protein molecule is not expected to significantly affect the ionization potential and thus allows for comparative analysis of the relative phosphorylation level between the different spectra. The presence of sodium adducts on some ions and not others is merely coincidental and are artifacts of the mass spectrometry procedure.
SDS-PAGE and Western Blotting Analysis-Acid soluble proteins extracted from whole cells were run on 16% Tris/glycine gels (Novex/ Invitrogen) at 150 V for 3 h at room temperature. Proteins were transferred to a polyvinylidene difluoride membrane for 2 h at 300 mA and probed using 1 g/l anti-histone H1 and phosphospecific histone H1 antibodies (Upstate Biotech) under standard conditions (28) .
RESULTS

Characterization and Purification of Histone H1 Isoforms-
Using immunological techniques, our laboratory has previously shown that histone H1 is progressively dephosphorylated in response to prolonged dexamethasone treatment (28) . However, this type of analysis is inherently limited, as the available phosphospecific antibody has been reported to recognize only one of the six H1 isoforms present, see below (33) . To gain a more complete picture of histone H1 phosphorylation status, we chose to examine the dexamethasone-induced changes in phosphorylation of the individual histone H1 isoforms by electrospray ionization mass spectrometry (ESI-MS). Prior to ESI-MS analysis, H1 proteins were acid-extracted from mouse 1471.1 cells and further purified from other acid soluble proteins using RP-HPLC. Samples were purified on a C 4 reverse phase column with a linear gradient from 33 to 45% organic phase over 65 min (Fig. 1) . A representative chromatogram for the purification of histone H1 from 1471.1 cells is shown in Fig.  1 , with the isoforms fractionating into two groups, Peak 1 and Peak 2. All the H1 samples analyzed by ESI-MS in this work were first purified by RP-HPLC as described above and exhibited a similar elution profile as shown in Fig. 1 (data not  shown) . There are six somatic histone H1 isoforms present in this mouse cell line, H1.0 though H1.5, yet only four bands are present on the 16% SDS-PAGE gel because H1.1, H1.3, and H1.4 isoforms co-migrate and are therefore not resolved (Fig. 1,  inset) .
Western Analysis of Samples Reveals the Phosphospecific H1 Antibody Recognizes a Subset of the Phosphorylated Histone H1 Isoforms-As observed by Lee and Archer (28) using Western analysis with the phosphospecific H1 antibody, a decrease in the level of histone H1 phosphorylation is observed after 48 h of dexamethasone treatment (Fig. 2A, lane 2) followed by subsequent re-phosphorylation upon washout of the hormone in the 24/24-hour conditions (Fig. 2A, lane 3) . Further analysis of the Western blot in comparison to the stained gel in Fig. 2A , illustrates that of four protein bands observed on the SDS gel only one band is recognized by the phosphospecific H1 antibody (compare the lower stained SDS-PAGE gel to the upper Western blot in Fig. 2A) . Furthermore, Fig. 2A clearly illustrates that the band recognized by the phosphospecific histone H1 antibody is from the RP-HPLC Peak 2 fraction. This protein band that is recognized by the antibody in Peak 2 contains the H1.1, H1.3, and H1.4 isoforms as determined by mass spectrometry in Fig. 3B . The other protein band observed on the SDS-PAGE gel from Peak 2 in Fig. 2A contains antibody (35) . However, we demonstrate that this antibody does not recognize any protein in Peak 1 (Fig. 2A, lane 4) , which contains the H1.0 and H1.5 isoforms as determined by mass spectrometry (Fig. 3A) . Although the Western blot analysis in Fig. 2A tells us that the H1.1, H1.3 , or H1.4 isoforms are exhibiting dexamethasone-induced changes in phosphorylation, the mass spectral data in Fig. 3A and B demonstrates that other isoforms are also phosphorylated. Therefore, other phosphorylated histone H1 isoforms that are invisible to the phosphospecific H1 antibody may also display dexamethasoneinduced changes in phosphorylation status, which ESI-MS will determine.
Additional Western analysis of the acid-extracted proteins using the anti-H1 antibody (which recognizes all histone H1 isoforms) in Fig. 2B, lane 2 illustrates that all bands observed on the stained gel (Fig. 2B, lane 1) are histone H1. As has been previously published, staurosporine can completely dephosphorylate histone H1 (28) . Western analysis using the phosphospecific H1 antibody ( Fig. 2C lane 2) confirms that histone H1 isolated from 1471.1 cells co-treated with staurosporine and dexamethasone does not contain measurable levels of phosphorylation. Staurosporine-dephosphorylated H1 samples from 1471.1 cells were subsequently used as a control for the mass spectrometry analysis of the untreated and dexamethasonetreated samples.
Prolonged Dexamethasone Treatment Dephosphorylates the H1.3, H1.4, and H1.5 Isoforms-From the ESI-MS analysis of histone H1 from 1471.1 cells (Fig. 3, A and B) , we show that the H1.0 and H1.5 isoforms are present in RP-HPLC Peak 1 and the H1.1, H1.2, H1.3, and H1.4 isoforms are present in RP-HPLC Peak 2 (see Table I for observed mass values). The mass spectra for Peak 1 and Peak 2 also illustrate that the H1 isoforms are monoacetylated and, except for H1.0, are phosphorylated to varying degrees. H1.2 exhibits the highest level of phosphorylation relative to the other H1 isoforms, with up to six phosphate groups present per protein molecule. However, not all of the total cellular H1.2 protein is fully saturated to the maximal level, but instead we see a range of protein phosphorylation that steps up in mass by 80 Da (one phosphate group) from one phosphate to a maximum of six phosphates. This kind of phosphorylation for H1.2, where the isoform is essentially unsaturated, is observed for all the isoforms expect for H1.0.
Of the six somatic histone H1 isoforms observed by ESI-MS, changes in phosphorylation resulting from dexamethasone or staurosporine treatments were observed only for the H1.3, H1.4, and H1.5 isoforms (Fig. 4, A, B, and C) . No differences were evident for the H1.0, H1.1, and H1.2 isoforms between the treated and untreated samples (Table I and Fig. 4A maintain a certain level of phosphorylation, the abundance of the 1P,1A ion (1 phosphate group and 1 acetyl group) relative to the unphosphorylated 1A ion for the 48-hour sample is decreased in comparison to the relative abundance of the same ions for the untreated and 24/24-hour samples. Therefore, these data suggest that the relative phosphorylation level of the H1.3 isoform is less in the 48-hour sample compared with the untreated and 24/24-hour samples. This pattern of phosphorylation was also seen for the H1.4 and H1.5 isoforms (Fig. 4, B and  C) and mimics the Western blot analysis of the same samples shown in Fig. 2A .
As mentioned above, the phosphospecific H1 antibody was shown to recognize a single band in the peak that contained H1.1, H1.3, and H1.4 isoforms (Fig. 2A) . Fig. 2C demonstrates that the H1 isoform(s) isolated from staurosporine-treated cells are completely dephosphorylated as determined by Western blot analysis using the phosphospecific H1 antibody. Interestingly, analysis of the ESI-MS data for the staurosporinetreated samples indicates that while H1.4 is phosphorylated, no detectable level of phosphorylation is evident for the H1.3 isoform (see Fig. 4 , A and B and Table II) . ESI-MS analysis also shows that the H1.0, H1.1, and H1.2 isoforms are relatively unaffected by staurosporine treatment (see Table I ). Therefore, these data led us to the conclusion that the phosphospecific H1 antibody specifically targets the phosphorylated H1.3 isoform. Moreover, the H1.2, H1.4, and H1.5 isoforms are more highly phosphorylated than H1.3 under all the conditions analyzed. For example, the H1.3-untreated sample in Fig. 4A has only one phosphate group per protein molecule while both the H1.4-and H1.5-untreated samples have up to two phosphate groups (Fig. 4, B and C) , and H1.2 has up to six phosphate groups per protein molecule (see Fig. 3B and Table I ). The observed mass values for all the isoforms from 1471.1 cells under the different dexamethasone and staurosporine treatments are listed in Table I . H1.0 is the only isoform that is completely unmodified and is predominately found in this unmodified state, relative to the monoacetylated form of the isoform (see Fig. 3A ). While all the other isoforms are monoacetylated, the H1.2 protein consists of a mixture of unacetylated and monoacetylated forms.
The total relative phosphorylation level of the H1.3, H1.4, and H1.5 isoforms under the different conditions is summarized in Table II (see "Materials and Methods" for details on computing total relative phosphorylation levels). These three H1 isoforms each exhibited a similar pattern of dephosphorylation after 48 hours of dexamethasone treatment with a concomitant re-phosphorylation after dexamethasone washout (24/24-hour Dex). The phosphorylation level of the H1.0, H1.1, and H1.2 isoforms did not significantly change under all conditions tested, and, therefore, are not included in Table II . Staurosporine appeared to affect phosphorylation of the H1.3 isoform most intensely such that H1.3 was completely dephosphorylated relative to what was observed with dexamethasone alone.
DISCUSSION
Post-translational modification of histones serves as a powerful yet reversible mechanism for regulating their function in cellular processes (9, 22, 23, 26, 36) . Numerous studies have shown an assortment of post-translational modifications (acetylation, methylation, phosphorylation, ubiquitination, and ADP-ribosylation) of the core and linker histones can modulate chromatin structure and function (reviewed in Refs. 22 and 26) . In fact, it has been suggested that combinations of modifications on histones in a localized area of chromatin may translate into some type of "histone code" that facilitates or signals other proteins to act (37) . To this end, differential modifications of the H1 isoforms have been reported; however, the contribution of these modifications toward the function of individual H1 isoforms in chromatin organization and gene regulation remains elusive (21, 38) . Lee and Archer (28) have suggested a direct connection between H1 phosphorylation and the transcriptional responsiveness of the MMTV promoter. It was reasoned that dephosphorylated histone H1 would repress chromatin remodeling and transcription factor loading by modulating the chromatin structure over the MMTV promoter (28) . As was observed using the 5 S rRNA gene, the mobility of precisely positioned nucleosomes was suppressed by the binding of histone H1 (39) and is the same type of mechanism expected for the MMTV promoter with its phased array of positioned nucleosomes. However, the Western blot technique employed previously (28) precluded the analysis of the phosphorylation status of the specific isoforms. The data here suggest that H1.3, H1.4, and H1.5 isoforms may be responsible for the refractory state of the MMTV promoter after prolonged hormone exposure. Furthermore, ESI-MS analysis of the staurosporine sample, showing only the complete dephosphorylation of the H1.3 isoform (Fig. 4A) , implicates H1.3 as the specific isoform responsible for modulating the chromatin structure over the MMTV promoter. Previously it was suggested that the phosphospecific antibody was recognizing phosphorylated H1.5 as its target (33, 35) . However, a combination of Western blot and ESI-MS analyses (Figs. 2 and  3 ) indicate that the phosphospecific antibody is recognizing either the H1.1, H1.3, or H1.4 isoforms. Because H1.3 is the only isoform completely dephosphorylated after staurosporine treatment (Fig. 4, compare A, panel d to B, panel d and C, panel  d) and no phosphoproteins were detected in the Western analysis of the staurosporine-treated samples (Fig. 2C) , the phosphospecific H1 antibody is most likely recognizing the phosphorylated form of the H1.3 isoform (Fig. 2A) .
Giancotti et al. (38) used mass spectrometry to show that mouse H1.0 is unmodified and H1.2 (H1c, Ref. 34) has up to five phosphate groups. Similar to our findings, they showed H1.2 was unsaturated with 2, 3, and 5 phosphate groups present (38) . In addition, Giancotti et al. (38) , showed that H1.3, H1.4, and H1.5 (H1.d, H1e, and H1b respectively) had a maximum of one phosphate group per isoform in mouse Lewis Lung Carcinoma, normal lung, thymus, and lymphoma tissue. Using acid/ urea gel electrophoresis, Talasz et al. (21) analyzed mouse histone H1 from NIH 3T3 fibroblasts, at different stages of the cell cycle. They separated the H1 isoforms into two groups: low phosphorylation levels H1.0, H1.1, and H1.2 (H1a, H1c, H10, Ref. 34 ) and high phosphorylation levels H1.3, H1.4, H1.5 (H1b, H1d, H1e, Ref. 34) . During mitosis, they found that the H1.1, H1.2, and H1.4 isoforms had four phosphate groups while H1.3 and H1.5 had five phosphate groups, but the levels of phosphorylation decreased significantly in G 1 phase. Differences in phosphorylation levels of the H1 isoforms observed in this work relative to Talasz et al. (21) are likely due to differences in cell type and origin.
The ability of a small negatively charged phosphate group to exert such a large influence over functional properties of histone H1 is not surprising. Although the H1 isoforms carry a high positive charge and the addition of 1 to 2 phosphate groups will not make significant changes to the overall charge of the protein, small localized changes in the DNA-contacting regions or in the secondary structure of the protein may be responsible for the observed phosphorylation induced effects (40) . Therefore, identifying the post-translational modifications of the individual isoforms will be important in defining their roles in activities such as gene-specific transcriptional regulation. In addition, identifying kinases, such as the cell cycle-dependent enzyme Cdk2, that may act on a subset of H1 isoforms in vivo will be important to understanding the functional significance of the various post-translational modifications (26) . From data to be published elsewhere, our laboratory has shown that dexamethasone inhibits Cdk2, and this inhibition is primarily responsible for the decline in H1 phosphorylation levels after prolonged dexamethasone exposure (27) . However the presence of numerous phosphorylated isoforms after prolonged dexamethasone and staurosporine treatment, i.e. H1.4 and H1.5, suggests that additional kinases, not sensitive to these compounds, are acting on the isoforms. Distribution of the H1 isoforms to distinct regions of the nucleus may also contribute to the differential functionality of the isoforms (41, 42) and such trafficking may depend on post-translational modifications of the proteins in response to varied stimuli (43, 44) . Future experiments will need to expand on the concept of individual histone H1 isoforms acting as gene-specific regulators of transcriptional activity through the modulation of chromatin structure.
